- Home
- CDIO vs CELZ Comparison
CDIO vs CELZ Comparison
Compare CDIO & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- CELZ
- Stock Information
- Founded
- CDIO 2017
- CELZ 1998
- Country
- CDIO United States
- CELZ United States
- Employees
- CDIO N/A
- CELZ N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- CDIO Health Care
- CELZ Health Care
- Exchange
- CDIO Nasdaq
- CELZ Nasdaq
- Market Cap
- CDIO 6.4M
- CELZ 7.4M
- IPO Year
- CDIO N/A
- CELZ N/A
- Fundamental
- Price
- CDIO $4.39
- CELZ $2.71
- Analyst Decision
- CDIO Buy
- CELZ
- Analyst Count
- CDIO 1
- CELZ 0
- Target Price
- CDIO $60.00
- CELZ N/A
- AVG Volume (30 Days)
- CDIO 41.0K
- CELZ 231.1K
- Earning Date
- CDIO 08-11-2025
- CELZ 08-08-2025
- Dividend Yield
- CDIO N/A
- CELZ N/A
- EPS Growth
- CDIO N/A
- CELZ N/A
- EPS
- CDIO N/A
- CELZ N/A
- Revenue
- CDIO $19,902.00
- CELZ $14,000.00
- Revenue This Year
- CDIO $1,434.82
- CELZ N/A
- Revenue Next Year
- CDIO $4,661.91
- CELZ N/A
- P/E Ratio
- CDIO N/A
- CELZ N/A
- Revenue Growth
- CDIO N/A
- CELZ 55.56
- 52 Week Low
- CDIO $3.22
- CELZ $1.69
- 52 Week High
- CDIO $53.10
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- CDIO 50.34
- CELZ 51.69
- Support Level
- CDIO $4.11
- CELZ $2.70
- Resistance Level
- CDIO $4.73
- CELZ $2.85
- Average True Range (ATR)
- CDIO 0.33
- CELZ 0.31
- MACD
- CDIO 0.10
- CELZ -0.03
- Stochastic Oscillator
- CDIO 65.03
- CELZ 18.95
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.